What is the clinical and cost effectiveness of positron emission tomography/computed tomography (PET/CT) compared to alternate diagnostic imaging modalities in the investigation of paraneoplastic neurological syndrome (PNS) to assist in the diagnosis of cancer? Assuming diagnosis using PET/CT is clinically and cost effective, at what stage should it be used in the diagnostic pathway?
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 23 January 2020)
Tomography, Emission
Cancer